Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID vaccine immunity is waning — how much does that matter?
Elie Dolgin
Nature (2021) Vol. 597, Iss. 7878, pp. 606-607
Open Access | Times Cited: 121

Showing 1-25 of 121 citing articles:

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
Daniel R. Feikin, Melissa M. Higdon, Laith J. Abu‐Raddad, et al.
The Lancet (2022) Vol. 399, Iss. 10328, pp. 924-944
Open Access | Times Cited: 1082
COVID-19 vaccination: The road ahead
Daniel M. Altmann, Rosemary J. Boyton
Science (2022) Vol. 375, Iss. 6585, pp. 1127-1132
Closed Access | Times Cited: 180
Retrospectively modeling the effects of increased global vaccine sharing on the COVID-19 pandemic
Sam Moore, Edward M. Hill, Louise Dyson, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2416-2423
Open Access | Times Cited: 81
Determinants of COVID-19 vaccine fatigue
Tanja Stamm, Julia Partheymüller, Erika Mosor, et al.
Nature Medicine (2023) Vol. 29, Iss. 5, pp. 1164-1171
Open Access | Times Cited: 54
COVID-19 vaccine and booster hesitation around the world: A literature review
Aashka Shah, Olivia C. Coiado
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 48
Overview of Neutralizing Antibodies and Their Potential in COVID-19
José Javier Morales‐Núñez, José Francisco Muñoz‐Valle, Paola Carolina Torres-Hernández, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1376-1376
Open Access | Times Cited: 67
An analysis of the COVID-19 vaccination campaigns in France, Israel, Italy and Spain and their impact on health and economic outcomes
Marcello Antonini, Marwa Atef Eid, Michelle Falkenbach, et al.
Health Policy and Technology (2021) Vol. 11, Iss. 2, pp. 100594-100594
Open Access | Times Cited: 54
Humoral and cellular response to COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases under real-life conditions
Marco Krasselt, Ulf Wagner, Phuong Nguyen, et al.
Lara D. Veeken (2022) Vol. 61, Iss. SI2, pp. SI180-SI188
Open Access | Times Cited: 47
Reduced Titers of Circulating Anti-SARS-CoV-2 Antibodies and Risk of COVID-19 Infection in Healthcare Workers during the Nine Months after Immunization with the BNT162b2 mRNA Vaccine
Luca Coppeta, Cristiana Ferrari, Giuseppina Somma, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 141-141
Open Access | Times Cited: 43
Influence of Seasonality and Public-Health Interventions on the COVID-19 Pandemic in Northern Europe
Gerry A. Quinn, Michael Connolly, Norman Fenton, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 334-334
Open Access | Times Cited: 7
Duration of Effectiveness of Vaccines Against SARS-CoV-2 Infection and COVID-19 Disease: Results of a Systematic Review and Meta-Regression
Daniel R. Feikin, Melissa M. Higdon, Laith J. Abu‐Raddad, et al.
SSRN Electronic Journal (2021)
Open Access | Times Cited: 50
The Role of Risk Perception in Students’ COVID-19 Vaccine Uptake: A Longitudinal Study
Femke Hilverda, Manja Vollmann
Vaccines (2021) Vol. 10, Iss. 1, pp. 22-22
Open Access | Times Cited: 50
Percentages of Vaccination Coverage Required to Establish Herd Immunity against SARS-CoV-2
Pedro Plans-Rubió
Vaccines (2022) Vol. 10, Iss. 5, pp. 736-736
Open Access | Times Cited: 34
mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron
Hye‐Kyung Lee, Ludwig Knabl, Juan I. Moliva, et al.
Cell Reports (2022) Vol. 39, Iss. 2, pp. 110680-110680
Open Access | Times Cited: 31
Immunogenicity and Safety of Homologous and Heterologous Prime–Boost Immunization with COVID-19 Vaccine: Systematic Review and Meta-Analysis
Haoyue Cheng, Zhicheng Peng, Shuting Si, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 798-798
Open Access | Times Cited: 31
Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine
Chandima Jeewandara, Inoka Sepali Aberathna, Pradeep Darshana Pushpakumara, et al.
Immunity Inflammation and Disease (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 31
The unnaturalistic fallacy: COVID-19 vaccine mandates should not discriminate against natural immunity
Jonathan Pugh, Julian Savulescu, Rebecca C. H. Brown, et al.
Journal of Medical Ethics (2022) Vol. 48, Iss. 6, pp. 371-377
Open Access | Times Cited: 30
A non-linear differential equation model of COVID-19 and seasonal influenza co-infection dynamics under vaccination strategy and immunity waning
Musa Rabiu, Olumuyiwa James Peter, Festus Abiodun Oguntolu
Healthcare Analytics (2023) Vol. 4, pp. 100240-100240
Open Access | Times Cited: 19
Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis
Shiyao Xu, Jincheng Li, Hongyuan Wang, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Efficacy of probiotic treatment as post-exposure prophylaxis for COVID-19: A double-blind, Placebo-Controlled Randomized trial
Paul E. Wischmeyer, Helen Tang, Yi Ren, et al.
Clinical Nutrition (2023) Vol. 43, Iss. 1, pp. 259-267
Open Access | Times Cited: 16
The Effect of Vaccination on the Competitive Advantage of Two Strains of an Infectious Disease
Matthew D. Johnston, Bruce Pell, Jared Pemberton, et al.
Bulletin of Mathematical Biology (2025) Vol. 87, Iss. 2
Open Access
Natural Products for the Prevention and Control of the COVID-19 Pandemic: Sustainable Bioresources
Rajeev K. Singla, Xuefei He, Hitesh Chopra, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 34
Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trial
Lairun Jin, Rong Tang, Shipo Wu, et al.
Emerging Microbes & Infections (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Daily Lactobacillus Probiotic versus Placebo in COVID-19-Exposed Household Contacts (PROTECT-EHC): A Randomized Clinical Trial
Paul E. Wischmeyer, Helen Tang, Yi Ren, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 22
COVID-19 lateral flow IgG seropositivity and serum neutralising antibody responses after primary and booster vaccinations in Chile: a cross-sectional study
Denis Sauré, Miguel O’Ryan, Juan Pablo Torres, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 3, pp. e149-e158
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top